Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Small Intestinal Neuroendocrine Tumor 1 Papillomavirus Infections 1 Pancreatic Adenocarcinoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Heart Failure 1 Cystic Fibrosis 1 Cardiomyopathies 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Dexamethasone 420 Lenalidomide 265 Cyclophosphamide 246 Bortezomib 242 Melphalan 192 Calcium Dobesilate 166 fludarabine phosphate 112 daratumumab 103 Peripheral Blood Stem Cell Transplantation 99 carfilzomib 92 Thalidomide 90 Filgrastim 88 Mycophenolic Acid 82 fludarabine 81 pomalidomide 80 Whole-Body Irradiation 80 Busulfan 74 Tacrolimus 71 Granulocyte Colony-Stimulating Factor 66 Cyclosporine 58 dexamethasone acetate 56 ixazomib 55 Antilymphocyte Serum 50 dexamethasone 21-phosphate 49 auricularum 44 isatuximab 40 Etoposide 39 Radiotherapy 36 Stem Cell Transplantation 34 Methotrexate 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Multiple Myeloma × Electronic Health Records × Clear all

NCT03638232 2018-08-20

Myeloma Treatment in Real Life

University Hospital, Toulouse

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡